Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma.

Kawanishi, Masaru; Fukuda, Takeshi; Shimomura, Masahiro; Inoue, Yuta; Wada, Takuma; Tasaka, Reiko; Yasui, Tomoyo; Sumi, Toshiyuki

Kawanishi, Masaru; Fukuda, Takeshi; Shimomura, Masahiro; Inoue, Yuta; Wada, Takuma; Tasaka, Reiko; Yasui, Tomoyo; Sumi, Toshiyuki.

Afiliação

Kawanishi M; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Fukuda T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Shimomura M; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Inoue Y; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Wada T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Tasaka R; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Yasui T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Sumi T; Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.

Oncol Lett ; 15(6): 9923-9928, 2018 Jun.

Article em En | MEDLINE | ID: mdl-29928365

Palavras-chave

carboplatin; chemotherapy; ovarian serous carcinoma; predictive marker; uncoupling protein 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google